-
公开(公告)号：US20220024945A1
公开(公告)日：2022-01-27
申请号：US17449398
申请日：2021-09-29
Applicant: Genentech, Inc.
Inventor： Mark ZAK , F. Anthony ROMERO , Yun-Xing CHENG , Wei LI
IPC: C07D498/04 , C07D487/04 , A61P11/00
Abstract: Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
-
![8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF](/abs-image/US/2023/08/03/US20230242530A1/abs.jpg.150x150.jpg)
2.发明公开公开(公告)号：US20230242530A1
公开(公告)日：2023-08-03
申请号：US18297546
申请日：2023-04-07
Applicant: Genentech, Inc.
Inventor： Simon Charles GOODACRE , Mark ZAK , F. Anthony ROMERO , Yun-Xing CHENG , Limin CHENG , Rongbao HUA
IPC: C07D471/04 , A61P11/06 , C07D519/00
CPC classification number: C07D471/04 , A61P11/06 , C07D519/00
Abstract: Compounds of Formula (I) and (II), or a stereoisomer, tautomer, solvate, prodrug or salt thereof, and methods of use as Janus kinase inhibitors are described herein.
-
![8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF](/abs-image/US/2020/08/27/US20200270248A1/abs.jpg.150x150.jpg)
3.发明申请公开(公告)号：US20200270248A1
公开(公告)日：2020-08-27
申请号：US16870602
申请日：2020-05-08
Applicant: Genentech, Inc.
Inventor： Simon Charles GOODACRE , Mark ZAK , F. Anthony ROMERO , Yun-Xing CHENG , Limin CHENG , Rongbao HUA
IPC: C07D471/04 , A61P11/06 , C07D519/00
Abstract: Compounds of Formula (I) and (II), or a stereoisomer, tautomer, solvate, prodrug or salt thereof, and methods of use as Janus kinase inhibitors are described herein.
-
公开(公告)号：US20200002346A1
公开(公告)日：2020-01-02
申请号：US16561447
申请日：2019-09-05
Applicant: Genentech, Inc.
Inventor： Mark ZAK , F. Anthony ROMERO , Po-wai YUEN , Emily J. HANAN
IPC: C07D487/04 , C07D471/04 , C07D491/048 , C07D498/04 , C07D513/04
Abstract: Compounds of Formula I and methods of use as Janus kinase inhibitors are described herein.
-
公开(公告)号：US20200062779A1
公开(公告)日：2020-02-27
申请号：US16668714
申请日：2019-10-30
Applicant: Genentech, Inc.
Inventor： Mark ZAK , F. Anthony ROMERO , Yun-Xing CHENG , Wei LI
IPC: C07D498/04 , A61P11/00 , C07D487/04
Abstract: Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
-
Patent Agency Ranking
![8-(AZETIDIN-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF](/abs-image/US/2019/07/04/US20190202822A1/abs.jpg.150x150.jpg)
6.发明申请公开(公告)号：US20190202822A1
公开(公告)日：2019-07-04
申请号：US16293129
申请日：2019-03-05
Applicant: Genentech, Inc.
Inventor： Simon Charles GOODACRE , Mark ZAK , F. Anthony ROMERO , Yun-Xing CHENG , Limin CHENG , Rongbao HUA
IPC: C07D471/04 , C07D519/00 , A61P11/06
CPC classification number: C07D471/04 , A61P11/06 , C07D519/00
Abstract: Compounds of Formula (I) and (II), or a stereoisomer, tautomer, solvate, prodrug or salt thereof, and methods of use as Janus kinase inhibitors are described herein.
-
公开(公告)号：US20180334465A1
公开(公告)日：2018-11-22
申请号：US15984728
申请日：2018-05-21
Applicant: Genentech, Inc.
Inventor： Mark ZAK , F. Anthony ROMERO , Yun-Xing CHENG , Wei LI
IPC: C07D498/04
CPC classification number: C07D498/04 , A61P11/00 , C07D487/04
Abstract: Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
-
公开(公告)号：US20210179626A1
公开(公告)日：2021-06-17
申请号：US17174733
申请日：2021-02-12
Applicant: Genentech, Inc.
Inventor： Mark ZAK , F. Anthony ROMERO , Po-wai YUEN , Emily J. HANAN
IPC: C07D487/04 , C07D471/04 , C07D491/048 , C07D498/04 , C07D513/04
Abstract: Compounds of Formula I and methods of use as Janus kinase inhibitors are described herein.
-
公开(公告)号：US20190240227A1
公开(公告)日：2019-08-08
申请号：US16387187
申请日：2019-04-17
Applicant: Genentech, Inc.
Inventor： Mark ZAK , F. Anthony ROMERO , Yun-Xing CHENG
IPC: A61K31/519 , A61P11/06 , C07D487/04 , A61P29/00
CPC classification number: A61K31/519 , A61P11/06 , A61P29/00 , C07D487/04
Abstract: Compounds and salts thereof that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
-
公开(公告)号：US20180333416A1
公开(公告)日：2018-11-22
申请号：US15984747
申请日：2018-05-21
Applicant: Genentech, Inc.
Inventor： Mark ZAK , F. Anthony ROMERO , Yun-Xing CHENG
IPC: A61K31/519 , A61P11/06
CPC classification number: A61K31/519 , A61P11/06 , A61P29/00 , C07D487/04
Abstract: Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.021 seconds)
